Vivien Schäfer

433 total citations
12 papers, 241 citations indexed

About

Vivien Schäfer is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Vivien Schäfer has authored 12 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Vivien Schäfer's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Vivien Schäfer is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Vivien Schäfer collaborates with scholars based in Germany, United Kingdom and Czechia. Vivien Schäfer's co-authors include Thomas Ernst, Andreas Hochhaus, Jenny Rinke, Nils Winkelmann, Claudia Haferlach, Janine M. Ziermann, Mathias Schmidt, Alexander Kohlmann, Ekkehard Eigendorff and Susanne Schnittger and has published in prestigious journals such as Blood, Clinical Chemistry and British Journal of Haematology.

In The Last Decade

Vivien Schäfer

12 papers receiving 240 citations

Peers

Vivien Schäfer
Berna Beverloo Netherlands
Matthew Smith United Kingdom
Linda Gojenola United States
B. Hilda Ye United States
Vivien Schäfer
Citations per year, relative to Vivien Schäfer Vivien Schäfer (= 1×) peers Pamela Acha

Countries citing papers authored by Vivien Schäfer

Since Specialization
Citations

This map shows the geographic impact of Vivien Schäfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivien Schäfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivien Schäfer more than expected).

Fields of papers citing papers by Vivien Schäfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivien Schäfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivien Schäfer. The network helps show where Vivien Schäfer may publish in the future.

Co-authorship network of co-authors of Vivien Schäfer

This figure shows the co-authorship network connecting the top 25 collaborators of Vivien Schäfer. A scholar is included among the top collaborators of Vivien Schäfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivien Schäfer. Vivien Schäfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rinke, Jenny, et al.. (2023). Molecular‐defined clonal evolution in patients with classical myeloproliferative neoplasms. British Journal of Haematology. 202(2). 308–317. 4 indexed citations
2.
Rinke, Jenny, Vivien Schäfer, Thomas Schenk, et al.. (2022). ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia. Leukemia. 36(9). 2242–2249. 25 indexed citations
3.
Schäfer, Vivien, Helen White, Gareth Gerrard, et al.. (2021). Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network. Journal of Cancer Research and Clinical Oncology. 147(10). 3081–3089. 17 indexed citations
4.
Rinke, Jenny, et al.. (2019). 5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 145(11). 2835–2843. 12 indexed citations
5.
Winkelmann, Nils, Vivien Schäfer, Jenny Rinke, et al.. (2017). Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies. Journal of Cancer Research and Clinical Oncology. 143(12). 2511–2519. 6 indexed citations
6.
Rinke, Jenny, Jörg P. Müller, Markus Blaess, et al.. (2017). Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms. Leukemia. 31(9). 1936–1943. 23 indexed citations
7.
Usemann, Jakob, Thomas Ernst, Vivien Schäfer, Kai Lehmberg, & Karl Seeger. (2016). EZH2 mutation in an adolescent with Weaver syndrome developing acute myeloid leukemia and secondary hemophagocytic lymphohistiocytosis. American Journal of Medical Genetics Part A. 170(5). 1274–1277. 21 indexed citations
8.
Ernst, Thomas, Vivien Schäfer, Helen White, et al.. (2016). Assessment of Molecular Response in CML Patients with Atypical BCR-ABL Tanscripts. Recommendations By the EUTOS Collaboration. Blood. 128(22). 1918–1918. 1 indexed citations
9.
Schäfer, Vivien, Jana Ernst, Jenny Rinke, et al.. (2016). EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia. Journal of Cancer Research and Clinical Oncology. 142(7). 1641–1650. 28 indexed citations
10.
Schmidt, Mathias, Jenny Rinke, Vivien Schäfer, et al.. (2014). Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status. Leukemia. 28(12). 2292–2299. 88 indexed citations
11.
Ernst, Thomas, Mathias Schmidt, Jenny Rinke, et al.. (2014). Molecularly Defined Clonal Evolution in Patients with Chronic Myeloid Leukemia Independent of the BCR-ABL Status. Blood. 124(21). 4513–4513. 2 indexed citations
12.
Rinke, Jenny, Vivien Schäfer, Mathias Schmidt, et al.. (2013). Genotyping of 25 Leukemia-Associated Genes in a Single Work Flow by Next-Generation Sequencing Technology with Low Amounts of Input Template DNA. Clinical Chemistry. 59(8). 1238–1250. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026